← SynDRA
LUCITANIB
SynDRA canonical compound SYN0034486 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | KDR |
|---|
| Mechanism of action | VEGFR inhibitor |
|---|
All known targets
- FGFR1
- FLT1
- KDR
- FGFR2
- FLT4
- KIT
- PDGFRA
- PDGFRB
- RET
- CSF1R
Mechanisms of action (all sources)
- FGFR inhibitor
- VEGFR inhibitor
- FGFR1 INHIBITOR
- FLT1 INHIBITOR
- KDR INHIBITOR
- KIT INHIBITOR
- PDGFRA INHIBITOR
- PDGFRB INHIBITOR
- RET INHIBITOR
Cross-references
Synonyms
- AL-3810
- CO-3810
- E-3810
- S-80881
- S80881
- E-3810 amine
- PP449XA4BH
- S 80881
- CHEBI:65138
- AL3810
- lucitanibum
- RefChem:924964
- DTXCID9069847
- E-3810 free base
- Lucitanib [INN]
- Lucitanib [USAN:INN]
- UNII-PP449XA4BH
- Lucitanib(E3810)
- E-3810; Lucitanib
- Lucitanib (USAN/INN)
- LUCITANIB [USAN]
- LUCITANIB [WHO-DD]
- SCHEMBL381394
- GTPL7649
- orb1308358
- SCHEMBL29363689
- SCHEMBL29365836
- SCHEMBL29375046
- CHEBI:65209
- CUDVHEFYRIWYQD-UHFFFAOYSA-N
- GLXC-90358
- EX-A2052
- BDBM50399539
- EBC-13042
- MFCD09607817
- NSC782762
- NSC800786
- AKOS030526232
Look up LUCITANIB in the interactive SynDRA portal →